Divine Skin Inc. pioneers
dermatological biotechnology

Biotech investors can count on long-term growth and stability with Divine Skin Inc. (DSKX) because the company targets an insatiable demand for youth and beauty, plus its researchers always push the envelope of dermatological science, and sales and profits are growing at a rapid pace.

Since Divine Skin started trading in May 2010, the company's stock price has risen dramatically, driven by equally dramatic growth in revenue.

Sustained growth into the future is ensured by exciting new distribution agreements with retail chains like Neiman Marcus, offering 41 upscale stores and 28 clearance centers, and salon chains like Fantastic Sams, supplying 1300 franchise locations.

New international channels focus on Brazil, a rapidly expanding, ethnically diverse market of 201 million eager consumers.

About Divine Skin

Divine Skin Inc. develops, markets, and distributes personal-care products through cosmetics wholesalers, online retailers, specialty outlets, spas, salons, and medical offices in more than 20 countries.

DS Laboratories, its flagship brand, offers high-performance topical solutions for men and women to restore growth and radiance to hair; suppress dandruff and unwanted hair; control acne; maintain feminine hygiene; and reduce the appearance of cellulite, wrinkles, and double chins.

Divine Skin's management believes the company has established itself as a leader in topical therapies, especially hair-growth, through the aggressive pursuit of innovation and technology. Products employ comprehensive formulas with multiple methods of action against common skin conditions. Many utilize proprietary encapsulation techniques for improved bioavailability.

Abner Silva
Investor Relations
Divine Skin Inc.
1.407.342.4112
investors@divineskin.com